Pharmacotherapy for mild hypertension (Q24201327)

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Mortality over Four Years in SHEP Participants with a Low Ankle‐Arm Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Coronary heart disease and treatment of hypertension. Some Oslo Study data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Pharmacotherapy for hypertension in women of different races

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Research Coun

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

The Oslo study: CHD risk factors, socioeconomic influences, and intervention

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Correlates of ventricular ectopic activity in isolated systolic hypertension. SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension. The SHEP Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Australian therapeutic trial in mild hypertension

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Some lessons from systolic hypertension in the elderly program (SHEP)

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Cardiovascular morbidity and mortality in mild hypertension: the Australian Trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hyper

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Oslo study: treatment of mild hypertension. A five-year controlled drug study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

The Australian Therapeutic Trial in Mild Hypertension

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Oslo Hypertension Study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

Australian Therapeutic Trial in Mild Hypertension

1 reference

https://api.crossref.org/works/10.1002/14651858.CD006742.PUB2

7 January 2021

10.1002/14651858.CD006742.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22895954

1 reference

Consolidated OpenCitations Corpus – April 2017